FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
Archived on September 30, 2026. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 5:00 PM EST
- Posted
- January 16, 2026
- Notice type
- Special Notice
- NAICS
- 541714: Research and Development in Biotechnology (except Nanobiotechnology)
- Agency
- Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION
Notice details
- Office
- FDA Office of Acquisitions and Grants Services
- Place of performance
- Silver Spring, Maryland, 20993
- PSC
- AJ11: GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
- Last updated
- Nov 4, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- FDABAA-26-00123
- Notice ID
- 5622acb8db634d37b3b55d607e6ba561
Description
Amendment 03 - Updated the announcement document to version 2.0. Changes are highlighted throughout the document.
Amendment 02 - Save the date! the FY26 Virtual BAA day - 20 January 2026!
https://www.fda.gov/science-research/advancing-regulatory-science/2026-fda-broad-agency-announcement-day-01202026
Amendment 01 - Updated the announcement document to version 2.0. Changes are highlighted throughout the document.
In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas as well as sub areas of interest defined within the BAA that serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement.
FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Documents
Files (4)
- Download
FY26 BAA Notice_V3.pdf
760 KBAdded in Special Notice version 5Posted - Download
Cost Appendix 8 Preaward Survey Accounting System.pdf
1.4 MBAdded in Special Notice version 5Posted - Download
Cost Appendix 7 Proposal Template.xlsx
191 KBAdded in Special Notice version 1Posted - Download
Attachment 6 SOW Template.docx
15 KBAdded in Special Notice version 1Posted
Lifecycle
- 1Version 1Special NoticeArchived
FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
- 2Version 2Special NoticeArchived
FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
- 3Version 3Special NoticeArchived
FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
- 5Version 5Special NoticeArchivedCurrent
FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
- 6Version 6Award Notice
Type changed from Special Notice to Award Notice
FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
FDABAA-26-00123
Archive Date
Sep 30, 2026
Office Address
Rockville, MD, 20857